50-198-3189

Crry Rabbit anti-Mouse∣Rat, Polyclonal, Bioss

Manufacturer: Bioss

Select a Size

Pack Size SKU Availability Price
Each of 1 50-198-3189-Each-of-1 In Stock ₹ 36,897.75

50-198-3189 - Each of 1

₹ 36,897.75

In Stock

Quantity

1

Base Price: ₹ 36,897.75

GST (18%): ₹ 6,641.595

Total Price: ₹ 43,539.345

Antigen

Crry

Classification

Polyclonal

Conjugate

Unconjugated

Gene

CR1L

Gene Alias

5I2 antigen; Antigen 5I2; Complement C4b-binding protein CR-1-like protein; complement component (3b/4b) receptor 1-like; complement component 3b/4b receptor 1-like; Complement component receptor 1-like protein; Complement receptor related protein; complement receptor type 1; complement receptor type 1-like; Complement regulatory protein Crry; Cr1; CR1L; Crry; LOC102157092; MGC129536

Host Species

Rabbit

Purification Method

Protein A

Regulatory Status

RUO

Gene ID (Entrez)

12946, 54243

Content And Storage

-20°C

Form

Liquid

Applications

Western Blot

Concentration

1 μg/mL

Formulation

PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH

Gene Accession No.

Q63135, Q64735

Gene Symbols

CR1L

Immunogen

KLH conjugated synthetic peptide derived from human Crry.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Mouse, Rat

Product Type

Antibody

Isotype

IgG

Related Products

Img

Bioss

50-198-3440

--

Img

Bioss

50-198-3656

--

Img

Bioss

50-198-3436

--

Img

Bioss

50-198-3877

--

Img

Bioss

50-198-4058

--

Img

Bioss

50-198-3040

--

Img

Bioss

50-198-3712

--

Img

Bioss

50-198-3947

--

Description

  • Description This gene encodes a membrane-bound inhibitor of complement activation, which contains several tandemly arranged short consensus repeats (SCRs) of approximately 60 amino acids
  • The encoded protein may play a role in tumor immune surveillance, which is unrelated to complement inhibition
  • Three alternatively spliced transcript variants encoding distinct isoforms have been found for this gene.

Compare Similar Items

Show Difference

Img

Bioss

50-198-3189

--


Antigen:
Crry

Classification:
Polyclonal

Conjugate:
Unconjugated

Gene:
CR1L

Gene Alias:
5I2 antigen; Antigen 5I2; Complement C4b-binding protein CR-1-like protein; complement component (3b/4b) receptor 1-like; complement component 3b/4b receptor 1-like; Complement component receptor 1-like protein; Complement receptor related protein; complement receptor type 1; complement receptor type 1-like; Complement regulatory protein Crry; Cr1; CR1L; Crry; LOC102157092; MGC129536

Host Species:
Rabbit

Purification Method:
Protein A

Regulatory Status:
RUO

Gene ID (Entrez):
12946, 54243

Content And Storage:
-20°C

Form:
Liquid

Applications:
Western Blot

Concentration:
1 μg/mL

Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH

Gene Accession No.:
Q63135, Q64735

Gene Symbols:
CR1L

Immunogen:
KLH conjugated synthetic peptide derived from human Crry.

Quantity:
100 μL

Primary or Secondary:
Primary

Target Species:
Mouse, Rat

Product Type:
Antibody

Isotype:
IgG

Img

Bioss

50-198-3190

--


Antigen:
H-1 beta

Classification:
Polyclonal

Conjugate:
Unconjugated

Gene:
ARNT

Gene Alias:
AHA-1; Arnt; ARNT protein; Arnt1; ARNT1a; ARNT1b; aryl hydrocarbon receptor nuclear translocater; Aryl hydrocarbon receptor nuclear translocator; Aryl hydrocarbon receptor nuclear translocator 1; aryl hydrocarbon receptor nuclear translocator type 1a; aryl hydrocarbon receptor nuclear translocator type 1b; BHLHE2; BOS_2904; Class E basic helix-loop-helix protein 2; D3Ertd557e; Dioxin receptor, nuclear translocator; Drnt; ESTM42; HIF1 beta; HIF-1 beta; Hif1b; HIF1BETA; HIF-1beta; HIF-1-beta; HIF1-beta; hypoxia-inducible factor 1 beta; hypoxia-inducible factor 1, beta subunit; Hypoxia-inducible factor 1-beta; mKIAA4051; TANGO; W08714; zgc:136664

Host Species:
Rabbit

Purification Method:
Protein A

Regulatory Status:
RUO

Gene ID (Entrez):
405

Content And Storage:
-20°C

Form:
Liquid

Applications:
Immunofluorescence, Immunohistochemistry (Paraffin), Western Blot

Concentration:
1 μg/mL

Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH

Gene Accession No.:
P27540

Gene Symbols:
ARNT

Immunogen:
KLH conjugated synthetic peptide derived from human HIF-1 Beta .

Quantity:
100 μL

Primary or Secondary:
Primary

Target Species:
Human

Product Type:
Antibody

Isotype:
IgG

Img

Bioss

50-198-3191

--


Antigen:
ERCC6

Classification:
Polyclonal

Conjugate:
Unconjugated

Gene:
ERCC6

Gene Alias:
4732403I04; ARMD5; ATP-dependent helicase ERCC6; C130058G22Rik; Chimeric CSB-PGBD3 protein; Chimeric ERCC6-PGBD3 protein; CKN2; Cockayne syndrome group B protein; Cockayne syndrome protein CSB; COFS; COFS1; CS group B correcting; Csb; DNA excision repair protein ERCC-6; DNA excision repair protein ERCC-6; ERCC6-PGBD3 fusion protein; ERCC excision repair 6, chromatin remodeling factor; ERCC6; ERCC6-PGBD3 fusion protein (isoform 1); excision repair cross-complementation group 6; excision repair cross-complementing rodent repair deficiency, complementation group 6; POF11; RAD26; UVSS1

Host Species:
Rabbit

Purification Method:
Protein A

Regulatory Status:
RUO

Gene ID (Entrez):
2074

Content And Storage:
-20°C

Form:
Liquid

Applications:
Immunofluorescence, Immunohistochemistry (Paraffin)

Concentration:
1 μg/mL

Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH

Gene Accession No.:
Q03468

Gene Symbols:
ERCC6

Immunogen:
KLH conjugated synthetic peptide derived from human ERCC6.

Quantity:
100 μL

Primary or Secondary:
Primary

Target Species:
Human

Product Type:
Antibody

Isotype:
IgG

Img

Bioss

50-198-3193

--


Antigen:
CT45A

Classification:
Polyclonal

Conjugate:
Unconjugated

Gene:
CT45A10

Gene Alias:
Cancer/testis antigen 45-1; Cancer/testis antigen 45-3; Cancer/testis antigen 45-4; cancer/testis antigen 45-4/6; Cancer/testis antigen 45-5; Cancer/testis antigen 45-6; Cancer/testis antigen 45A1; Cancer/testis antigen 45A10; Cancer/testis antigen 45A3; Cancer/testis antigen 45A4; cancer/testis antigen 45A4/45A6; Cancer/testis antigen 45A5; Cancer/testis antigen 45A6; Cancer/testis antigen 45A7; cancer/testis antigen CT45-1; cancer/testis antigen CT45-3; cancer/testis antigen CT45-5; cancer/testis antigen CT45-6; Cancer/testis antigen family 45 member A1; Cancer/testis antigen family 45 member A10; Cancer/testis antigen family 45 member A3; Cancer/testis antigen family 45 member A4; cancer/testis antigen family 45 member A4/A6; Cancer/testis antigen family 45 member A5; Cancer/testis antigen family 45 member A6; Cancer/testis antigen family 45 member A7; cancer/testis antigen family 45 member A-like; cancer/testis antigen family 45, member A1; cancer/testis antigen family 45, member A10; cancer/testis antigen family 45, member A3; cancer/testis antigen family 45, member A4; cancer/testis antigen family 45, member A5; cancer/testis antigen family 45, member A6; CT45; CT45.1; CT45.3; CT45.4; CT45.5; CT45.6; CT45-1; CT45-3; CT45-4; CT455; CT45-5; CT45-6; CT45A1; CT45A10; CT45A3; CT45A4; CT45A5; CT45A6; CT45A7

Host Species:
Rabbit

Purification Method:
Protein A

Regulatory Status:
RUO

Gene ID (Entrez):
102723631, 441519, 441521, 541465, 541466

Content And Storage:
-20°C

Form:
Liquid

Applications:
Immunohistochemistry (Paraffin)

Concentration:
1 μg/mL

Formulation:
PBS with 1% BSA, 50% glycerol and 0.09% sodium azide; pH

Gene Accession No.:
P0DMU7, P0DMU8, P0DMU9, Q5HYN5, Q8NHU0

Gene Symbols:
CT45A1, CT45A10, CT45A3, CT45A5, CT45A6

Immunogen:
KLH conjugated synthetic peptide derived from human CT45A3.

Quantity:
100 μL

Primary or Secondary:
Primary

Target Species:
Human

Product Type:
Antibody

Isotype:
IgG